FDA Reviews Possible Risk Of Rare Cancer From Bone Drugs

Some research suggests there may be an increased risk of esophageal cancer for people who take some popular osteoporosis medicines. The Food and Drug Administration is reviewing the data but says there isn't enough information to draw a firm conclusion Read More...

Read the complete post at http://www.npr.org/blogs/health/2011/07/21/138579813/fda-reviews-possible-risk-of-rare-cancer-from-bone-drugs?ft=1&f=103537970


Posted Jul 21 2011, 01:33 PM by NPR Blogs: Shots - Health Blog